Respiratory disorders
17 results
Applied filters
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists will use a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
The licence and supporting evidence for omalizumab biosimilar
14 November 2025We highlight evidence for licensed omalizumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Xolair).
Preparing to use omalizumab biosimilar
19 September 2025Omalizumab biosimilars are expected soon. We offer general information and implementation advice.
Doxycycline for sinusitis
27 January 2025SPS PGD template for the supply of doxycycline for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Fluticasone furoate nasal spray for sinusitis
27 January 2025SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.
Clarithromycin for sore throat
27 January 2025SPS PGD template for the supply of clarithromycin for sore throat in those with a penicillin allergy.
Clarithromycin for otitis media
27 January 2025SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.
Mometasone furoate monohydrate nasal spray for sinusitis
27 January 2025SPS PGD template for the supply of mometasone furorate monohydrate nasal spray for sinusitis.
Penicillin V (phenoxymethylpenicillin) for sinusitis
27 January 2025SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.
Penicillin V (phenoxymethylpenicillin) for sore throat
27 January 2025SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) for sore throat.